If you missed on Moderna $MRNA +150%, Don’t Miss CorMedix $CRMD — 1X -2X setup
$CRMD$MRNA
AI SUMMARY — Post highlights CorMedix (CRMD) as a potential growth opportunity similar to Moderna's past performance, suggesting a 1-2x upside setup. Key risks include biotech volatility, clinical trial outcomes, regulatory approval uncertainty, and the speculative nature of comparing to past outlier performers.
| TICKER | CRMD |
USER | u/Flaky_Rhubarb_6738 |
| RATING |
BULLISH |
ENTRY |
$8.20
|
| POSITION |
609 sh
SYN
|
BOOK VAL |
$4996.95 |
| CURRENT |
$8.20 |
P&L % |
+0.06%
|
| CURR VAL |
$5000.00 |
P&L $ |
+3.05
|
| TICKER | MRNA |
USER | u/Flaky_Rhubarb_6738 |
| RATING |
BULLISH |
ENTRY |
$145.04
|
| POSITION |
34 sh
SYN
|
BOOK VAL |
$4996.90 |
| CURRENT |
$145.13 |
P&L % |
+0.06%
|
| CURR VAL |
$5000.00 |
P&L $ |
+3.10
|